Nine More Years? Sandoz Loses Again On Enbrel Biosimilar

Sandoz Has Held FDA Approval For Its Erelzi Version Since 2016

 
• By Dean Rudge
  
2029_Ice
Sandoz' biosimilar etanercept launch plans may be on ice until 2029 • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin